Home›Search›Hematology, Transfusion and Cell Therapy

Hematology, Transfusion and Cell Therapy

Elsevier Editora Ltda · Brazil · Est. 1977

ISSN2531-1387

SJR Q3✓ Scopus / SJR✓ DOAJ✓ Open Access

/ 100

High Risk

Score Breakdown

✓ Scopus Q3+12

✓ DOAJ Verified+15

Total37

Journal Impact Factor

Not on record at PubScope. The Journal Impact Factor is published by Clarivate for Web of Science (JCR)–indexed journals. If this journal has one, it appears on the journal’s page ↗

SJR Score

0.36

H-Index

CiteScore

View ↗

Scopus metric · on the journal’s page

SNIP

0.754

Total Works

10,988

Total Citations

7,479

2yr Mean Citedness

0.08

Free JIF alternative

Retractions

Source: Retraction Watch

Aims & Scope✦ Inferred from recent articles

This journal focuses on hematological diseases, blood transfusions, and cell therapies. It covers topics such as the diagnosis and management of specific conditions like immunoglobulin light chain amyloidosis, sickle cell disease, and various leukemias. The scope also includes research on blood component utilization, stem cell mobilization, and the use of diagnostic markers like immature platelet fraction. Additionally, it addresses cell-based therapies, including natural killer cell therapy and hematopoietic stem cell transplantation, and explores the impact of genetic factors and treatment strategies on patient outcomes.

AI-summarised from recent articles · verify on publisher page →

⚡ Speed vs Prestige

How does this journal balance review speed with impact level?

weeks to review

Slow · median is 15 wks

SJR Rank

Top 75% in field

General Information

Country / RegionBrazil

Primary LanguageEnglish

1st Year Published1977

Annual Volume~ 2,277 articles / year

StatusActive (last: 2026)

Total Publications10,988

Publisher OrgElsevier BV

OA Since2017

Visit Journal Website

Submission Info

APC Cost💎 Diamond OA — Free

Peer ReviewDouble-blind

Review Time~30 weeks

Acceptance Rate—

OA LicenseCC BY, CC BY-NC-ND

OA Rate—

Ethics & Quality

COPE Member✗ No

OASPA Member✗ No

Not on Predatory Lists✓ Yes

Plagiarism Detection✓ Yes

📦 Long-term Preservation

PorticoPMCCLOCKSS

Think.Check.Submit Compliance

thinkchecksubmit.org

11/12 · 92%

✅

Do you know the journal / publisher?

Elsevier Editora Ltda

✅

Does the journal have a website?

✓ Linked

✅

Is the ISSN verified?

2531-1387

✅

Indexed in a trusted database?

Scopus, DOAJ

✅

Peer review process documented?

Double-blind

❌

Follows ethical publishing standards (COPE)?

N/A

✅

APC fees clearly disclosed?

No APC (Free)

✅

Not on predatory/blacklists?

✓ Clean

✅

Long-term digital preservation?

Portico, PMC, CLOCKSS

✅

Plagiarism detection in place?

Yes

✅

Listed in DOAJ (verified OA)?

DOAJ verified

✅

Primary language documented?

English

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published

Times cited

2019

2020

2021

2022

2023

2024

2025

2026

Source: OpenAlex · Note: citations accumulate over time so older years appear higher

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.

HematologyQ3

Immunology and AllergyQ3

Subject Classification

Scopus Categories

HematologyImmunology and Allergy

Research Topics (OpenAlex)

Hemoglobinopathies and Related DisordersAcute Myeloid Leukemia ResearchBlood donation and transfusion practicesChronic Lymphocytic Leukemia ResearchAcute Lymphoblastic Leukemia researchIron Metabolism and DisordersHealthcare during COVID-19 PandemicChronic Myeloid Leukemia TreatmentsLymphoma Diagnosis and TreatmentBlood groups and transfusion